Out of the 386 regencies and mayoralties targeted by the Health Ministry, fewer than half are estimated to have public health ...
Fulgent is set to buy Bako Diagnostics assets and StrataDx for $55.5M, expanding into anatomic pathology and dermatopathology to scale lab services.
Delafloxacin may be more effective than current treatments at inhibiting intracellular replication of bacteria genus ...
The US Food and Drug Administration cleared a number of molecular tests and immunoassays, as well as a clinical chemistry and a cellular deformation test.
Detailed price information for Fulgent Genetics Inc (FLGT-Q) from The Globe and Mail including charting and trades.
NEW YORK – Fulgent Genetics announced on Monday that it has entered into a definitive agreement to acquire lab service provider StrataDx, as well as certain assets of Bako Diagnostics. Fulgent said it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback